Filter Results


Study status

(for at least one location)



Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 61 for (lung OR pulmonary) AND surgery

Edit search filters
  1. Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study

    Rochester, MN

  2. Pulmonary Rehabilitation Before Lung Cancer Resection

    Jacksonville, FL, Rochester, MN

  3. LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

    Rochester, MN

  4. Open-Label, Extension Trial to Demonstrate the Effectiveness and Safety of L-CsA Plus Standard of Care in the Treatment of BOS in Patients Post Single or Double Lung Transplant

    Jacksonville, FL

  5. MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

    Rochester, MN

  6. Radiation Therapy in Treating Patients with Extensive Stage Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  7. Study of Cryoablation for Metastatic Lung Tumors

    Rochester, MN

  8. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  9. The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors

    Rochester, MN

  10. A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants

    Scottsdale/Phoenix, AZ, Rochester, MN


Mayo Clinic Footer